A month has gone by since the last earnings report for Applied Industrial Technologies (AIT). Shares have added about 10.7% in that time frame, outperforming the S&P 500.
A month has gone by since the last earnings report for Arthur J. Gallagher (AJG). Shares have added about 20.1% in that time frame, outperforming the S&P 500.
A month has gone by since the last earnings report for Atlassian Corporation PLC (TEAM). Shares have added about 19.2% in that time frame, outperforming the S&P 500.
It has been about a month since the last earnings report for Wesco International (WCC). Shares have added about 28.7% in that time frame, outperforming the S&P 500.
It has been about a month since the last earnings report for ConocoPhillips (COP). Shares have added about 0.2% in that time frame, underperforming the S&P 500.
A month has gone by since the last earnings report for Agios Pharmaceuticals (AGIO). Shares have added about 25.8% in that time frame, outperforming the S&P 500.
A month has gone by since the last earnings report for CRA International (CRAI). Shares have lost about 4.1% in that time frame, underperforming the S&P 500.
It has been about a month since the last earnings report for Altra Industrial Motion (AIMC). Shares have added about 11.1% in that time frame, outperforming the S&P 500.
The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
(RTTNews) - The safety of malaria drug Hydroxychloroquine, which was touted by President Trump as a "game-changer" in the fight against coronavirus, has been called into question and the WHO has now temporarily halted trials involving this drug in several countries.
Teva Pharmaceutical Industries (NYSE: TEVA) is a well known generic drugmaker that's attracted the attention of a number of well-known investors in the past. Most notably, Warren Buffett's Berkshire Hathaway bought shares of the company a number of years ago due, in no small p
Charlotte's Web (OTC: CWBHF) stock is up by about 40% in the past month -- which is far better than the Horizons Marijuana Life Sciences ETF (OTC: HMLSF) has performed during that time, with returns of about 20%. The hemp company's gotten a boost from its first-quarter results,
Shares of Moderna (NASDAQ: MRNA) were soaring earlier this month when the company released interim results from its mRNA vaccine. Investors were bullish on the possible COVID-19 vaccine, sending the stock to an all-time high of $87. It's since fallen more than 35% since then as
According to Independent Vermont Senator Bernie Sanders in his 2016 book, Our Revolution, "Social Security is the most successful government program in our nation's history." And he's right.
The Motley Fool
Checked
11 minutes 54 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article